Expression profiling of G2/M phase regulatory proteins in normal, premalignant and malignant uterine cervix and their correlation with survival of patients

Journal of Cancer Research and Therapeutics

Volumn 6, Issue 2, 2010, Pages 167-171

  Chhavi, ^a   Saxena, Mona ^b   Singh, Sharad ^a   Negi, M P S ^c   Srivastava, Anupam K ^a   Trivedi, Ritu ^d   Singh, Urmila ^a   Pant, M C ^a   Bhatt, M L B ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

^b Career Post Graduate Institute of Dental Sciences and Hospital   (India)

^c Biometry and Statistics Division   (Germany)

^d CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Aurora B; cervix cancer; Cyclin B; LIMKinase1 (LIMK1); Polo Like Kinase1 (PLK1)

Indexed keywords

AURORA B KINASE; CELL CYCLE PROTEIN; CYCLIN B1; LIM KINASE 1; POLO LIKE KINASE 1; AURKB PROTEIN, HUMAN; AURORA KINASE; LIM KINASE; LIMK1 PROTEIN, HUMAN; ONCOPROTEIN; POLO-LIKE KINASE 1; PROTEIN SERINE THREONINE KINASE;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION; UTERINE CERVIX; UTERINE CERVIX CANCER; UTERINE CERVIX DYSPLASIA; UTERINE CERVIX TUMOR; CANCER STAGING; CASE CONTROL STUDY; CELL DIVISION; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; PRECANCER; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA IN SITU; WESTERN BLOTTING; YOUNG ADULT;

ADULT; AGED; AURORA KINASE B; AURORA KINASES; BLOTTING, WESTERN; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CELL DIVISION; CERVICAL INTRAEPITHELIAL NEOPLASIA; CYCLIN B1; FEMALE; G2 PHASE; GENE EXPRESSION PROFILING; HUMANS; LIM KINASES; MIDDLE AGED; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; SURVIVAL RATE; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77954989991     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.65242     Document Type: Article

References (32)

1. Dabash R, Vajpayee J, Jacob M, Dzuba I, Lal N, Bradley J, et al. A strategic assessment of cervical cancer prevention and treatment services in 3 districts of Uttar Pradesh, India. Reprod Health 2005;2:11, Available from: http://www.reproductive-health-journal.com/content/2/1/11 [last accessed on 2009 January 13]
2. Bobba R, Khan Y. Cancer in India: An overview. GOR (Global Outsourcing Review) Winter 2003;5:95 Available from: http://www.pharm-olam.com/pdfs/ Cancer%20in%20India.pdf . [last accessed on 2010 May 20]
3. Shen M, Feng Y, Gao C, Tao D, Hu J, Reed E, et al. Detection of cyclin b1 expression in g(1)-phase cancer cell lines and cancer tissues by postsorting Western blot analysis. Cancer Res 2004;64:1607-1610
4. Andrews PD, Knatko E, Moore WJ, Swedlow JR. Mitotic mechanics: The auroras come into view. Curr Opin Cell Biol 2003;15:672-683
5. Weichert W, Schmidt M, Gekeler V, Denkert C, Stephan C, Jung K, et al. Polo-like kinase is overexpressed in prostate cancer and linked to higher tumor grades. Prostate 2004;60:240-245
6. Yamaguchi H, Condeelis J. Regulation of the actin cytoskeleton in cancer cell migration and invasion. Biochim Biophys Acta 2007;1773:642-652
7. Tyagi AK, Singh RP, Agarwal C, Chan DC, Agarwal R. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth inhibition, G2-M arrest, and apoptosis. Clin Cancer Res 2002;8:3512-3519
8. Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S. FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 2000;70:209-262
9. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275
10. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci U S A 1979;76:4350-4354
11. Zhao M, Kim YT, Yoon BS, Kim SW, Kang MH, Kim SH, et al. Expression profiling of cyclin B1 and D1 in cervical carcinoma. Exp Oncol 2006;28:44-48
12. Katayama H, Brinkley WR, Sen S. The Aurora kinases: Role in cell transformation and tumorigenesis. Cancer Metastasis Rev 2003;22:451-464
13. Nishimura Y, Yoshioka K, Bernard O, Bereczky B, Itoh K. A role of LIM kinase 1/cofilin pathway in regulating endocytic trafficking of EGF receptor in human breast cancer cells. Histochem Cell Biol 2006;126:627-638
14. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, et al. Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993;8:2127-2133
15. Archer SY, Johnson J, Kim HJ, Ma Q, Mou H, Daesety V, et al. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells. Am J Physiol Gastrointest Liver Physiol 2005;289:G696-703.
16. Tatsuka M, Katavama H, Ota T, Tanaka T, Odashima S, Suzuki F, et al. Multinuclearity and increased ploidy caused by overexpression of the aurora- and IpI1-like midbody-associated protein mitotic kinase in human cancer cells. Cancer Res 1998;58:4811-4816
17. Nguyen HG, Chinnappan D, Urano T, Ravid K. Mechanism of Aurora-b degradation and its dependency on intact KEN and A-boxes: Identification of an aneuploidy-promoting property. Mol Cell Biol 2005;25:4977-4992
18. Qi G, Ogawa I, Kudo Y, Miyauchi M, Siriwardena BS, Shimamoto F, et al. Aurora-B expression and its correlation with cell proliferation and metastasis in oral cancer. Virchows Arch 2007;450:297-302.
19. Araki K, Nozaki K, Ueba T, Tatsuka M, Hashimoto N. High expression of Aurora-B/Aurora and Ipl1-like midbody-associated protein (AIM-1) in astrocytomas. J Neurooncol 2004;67:53-64.
20. Kurai M, Shiozawa T, Shih HC, Miyamoto T, Feng YZ, Kashima H, et al. Expression of Aurora kinases A and B in normal, hyperplastic, and malignant human endometrium: Aurora B as a predictor for poor prognosis in endometrial carcinoma. Hum Pathol 2005;36:1281-1288
21. Takahashi T, Sano B, Nagata T, Kato H, Sugiyama Y, Kunieda K, et al. Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers. Cancer Sci 2003;94:148-152
22. Weichert W, Denkert C, Schmidt M, Gekeler V, Wolf G, Kobel M, et al. Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma. Br J Cancer 2004;90:815-821
23. Lane HA, Nigg EA. Antibody microinjection reveals an essential role for human polo-like kinase 1 (PLK1) in the functional maturation of mitotic centrosomes. J Cell Biol 1996;135:1701-1713
24. Davila M, Frost AR, Grizzle WE, Chakrabarti R. LIM kinase1 is essential for the invasive growth of prostate epithelial cells: Implications in prostate cancer. J Biol Chem 2003;278:36868-36875
25. Yoshioka K, Foletta V, Bernard O, Itoh K. A role for LIM kinase in cancer invasion. Proc Natl Acad Sci U S A 2003;100:7247-7252
26. Aaltonen K, Amini RM, Heikkilä P, Aittomäki K, Tamminen A, Nevanlinna H, et al. High cyclin B1 expression is associated with poor survival in breast cancer. Br J Cancer 2009;100:1055-1060
27. Spänkuch-Schmitt B, Wolf G, Solbach C, Loibl S, Knecht R, Stegmüller M, et al. Downregulation of human polo-like kinase activity by antisense oligonucleotides induces growth inhibition in cancer cells. Oncogene 2002;21:3162-3171
28. Knecht R, Elez R, Oechler M, Solbach C, von Ilberg C, Strebhardt K. Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck. Cancer Res 1999;59:2794-2797
29. Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamanaka R, Miyakawa I. Expression of polo-like kinase in ovarian cancer is associated with histological grade and clinical stage. Cancer Lett 2001;164:41-49
30. Takai N, Miyazaki T, Fujisawa K, Nasu K, Hamanaka R, Miyakawa I. Polo-like kinase (PLK) expression in endometrial carcinoma. Cancer Lett 2001;169:41-49
31. Weichert W, Kristiansen G, Winzer KJ, Schmidt M, Gekeler V, Noske A, et al. Polo-like kinase isoforms in breast cancer: Expression patterns and prognostic implications. Virchows Arch 2005;446:442-450 (Pubitemid 40674853)
32. Feng YB, Lin DC, Shi ZZ, Wang XC, Shen XM, Zhang Y, et al. Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma. Int J Cancer 2009;124:578-588